Search research articles
Contact Us
Filters
Showing results (1-10 of 41) with videos related to
Page
of 5
Sort By:
International Journal of Cancer
|
September 25, 2024
The future of immunotherapy for diffuse large B-cell lymphoma
Johannes Duell, Jason Westin
Bone Marrow Transplantation
|
August 22, 2019
The use of bispecific antibodies to optimize the outcome of patients with acute leukemia, lymphoma and multiple myeloma after SCT
Hermann Einsele, Leo Rasche, Max S Topp, et al.
Clinical Pharmacology and Therapeutics
|
February 17, 2019
Bispecific Antibodies in the Treatment of Hematologic Malignancies
Johannes Duell, Philip E Lammers, Ivana Djuretic, et al.
Annals of Hematology
|
February 15, 2014
The lymphoma-like polychemotherapy regimen "Dexa-BEAM" in advanced and extramedullary multiple myeloma
Leo Rasche, Susanne Strifler, Johannes Duell, et al.
Plos One
|
May 14, 2013
The natural human IgM antibody PAT-SM6 induces apoptosis in primary human multiple myeloma cells by targeting heat shock protein GRP78
Leo Rasche, Johannes Duell, Charlotte Morgner, et al.
BMC Rheumatology
|
July 9, 2025
Comparison of T cell response to vaccination in rheumatic patients treated with Janus kinase inhibitors and TNF inhibitors
Sebastian Hüper, Florian Eisele, Johannes Duell, et al.
Journal of Cancer Research and Clinical Oncology
|
June 4, 2021
R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement
Maximilian J Steinhardt, Franziska C Krummenast, Andreas Rosenwald, et al.
Blood
|
August 7, 2009
Selective depletion of alloreactive T cells by targeted therapy of heat shock protein 90: a novel strategy for control of graft-versus-host disease
Claudia Stuehler, Stephan Mielke, Manik Chatterjee, et al.
Annals of Hematology
|
January 31, 2012
Features of extramedullary myeloma relapse: high proliferation, minimal marrow involvement, adverse cytogenetics: a retrospective single-center study of 24 cases
Leo Rasche, Corinna Bernard, Max S Topp, et al.
Journal for Immunotherapy of Cancer
|
January 11, 2025
Neuropsychiatric manifestations following chimeric antigen receptor T cell therapy for cancer: a systematic review of clinical outcomes and management strategies
Anna Fleischer, Sophia Kurth, Johannes Duell, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 41) with videos related to
Sort By:
Page
of 5
International Journal of Cancer
|
September 25, 2024
The future of immunotherapy for diffuse large B-cell lymphoma
Johannes Duell, Jason Westin
Bone Marrow Transplantation
|
August 22, 2019
The use of bispecific antibodies to optimize the outcome of patients with acute leukemia, lymphoma and multiple myeloma after SCT
Hermann Einsele, Leo Rasche, Max S Topp, et al.
Clinical Pharmacology and Therapeutics
|
February 17, 2019
Bispecific Antibodies in the Treatment of Hematologic Malignancies
Johannes Duell, Philip E Lammers, Ivana Djuretic, et al.
Annals of Hematology
|
February 15, 2014
The lymphoma-like polychemotherapy regimen "Dexa-BEAM" in advanced and extramedullary multiple myeloma
Leo Rasche, Susanne Strifler, Johannes Duell, et al.
Plos One
|
May 14, 2013
The natural human IgM antibody PAT-SM6 induces apoptosis in primary human multiple myeloma cells by targeting heat shock protein GRP78
Leo Rasche, Johannes Duell, Charlotte Morgner, et al.
BMC Rheumatology
|
July 9, 2025
Comparison of T cell response to vaccination in rheumatic patients treated with Janus kinase inhibitors and TNF inhibitors
Sebastian Hüper, Florian Eisele, Johannes Duell, et al.
Journal of Cancer Research and Clinical Oncology
|
June 4, 2021
R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement
Maximilian J Steinhardt, Franziska C Krummenast, Andreas Rosenwald, et al.
Blood
|
August 7, 2009
Selective depletion of alloreactive T cells by targeted therapy of heat shock protein 90: a novel strategy for control of graft-versus-host disease
Claudia Stuehler, Stephan Mielke, Manik Chatterjee, et al.
Annals of Hematology
|
January 31, 2012
Features of extramedullary myeloma relapse: high proliferation, minimal marrow involvement, adverse cytogenetics: a retrospective single-center study of 24 cases
Leo Rasche, Corinna Bernard, Max S Topp, et al.
Journal for Immunotherapy of Cancer
|
January 11, 2025
Neuropsychiatric manifestations following chimeric antigen receptor T cell therapy for cancer: a systematic review of clinical outcomes and management strategies
Anna Fleischer, Sophia Kurth, Johannes Duell, et al.
Page
of 5